Hygenix Blog

Pharma and biotech teams struggle with rising capital investment, tight timelines, and complex manufacturing…

In a …

Skilled labor is in short supply, and project schedules aren’t getting any easier. Teams often have enough people,…

On May 12, 2025, the FDA announced it would expand its use of generative AI across regulatory review processes,…

After an initial surge of reshoring announcements, 2025 has ushered in a more cautious phase for pharmaceutical…

In the last quarter, the FDA has issued a wave of warning letters and import alerts to pharmaceutical and medical…

Cleanroom construction is more than a capital project, it’s a compliance-critical investment that directly impacts…